MedTrace Logo

Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

NCT01226173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 182353

Last updated 2012-09-24

No results posted yet for this study

Summary

The purpose of the study is to screen blood donors for the presence of NS1 antigen of the dengue virus at the American Red Cross in Puerto Rico region (and Monroe County, Florida) using the Platelia Dengue NS1 Ag enzyme immunoassay.

Conditions

  • Mass Screening

Interventions

DEVICE

Bio-Rad Platelia Dengue NS1 Ag test

The purpose of the study is to screen blood donors for the presence of dengue NS1 antigen at the ARC in Puerto Rico region using the Bio-Rad Platelia Dengue NS1 Ag test.

Sponsors & Collaborators

Principal Investigators

  • Susan Stramer, PhD · American National Red Cross

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01226173 on ClinicalTrials.gov